Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Phani
Phani holds a BS in Biomedical Engineering and an MS in Biomedical Sciences from Rutgers, and an MS in Bioethics from Harvard. He's currently working on a NASA-funded project at Brigham and Women's.
Elizabeth
Elizabeth is an MD/PhD student at NYU School of Medicine's Medical Scientist Training Program. She holds a BA in Biology with a minor in English from Hunter College.